Menopause & Myths about Hormone Replacement Therapy
Post Updated February 7, 2022 For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN. So what can we…
Read More ➝
Posts
What You Need to Know About Estrogen and the KRAS-variant
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation which predicts an increased risk of cancer. Following this breakthrough, Dr. Weidhaas and…
Read More ➝
Let’s Talk Menopause (Finally)
Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. We all know something about menopause, but just like pregnancy or bungee jumping, you…
Read More ➝
Why you should get your KRAS-variant results
Dear study participants, I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study. While I always enjoy…
Read More ➝
The truth about GWAS and the KRAS-variant
Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice…
Read More ➝
How does breast cancer treatment impact second breast cancer risk?
We are embarking on a study to explore how breast cancer management strategies (e.g., chemotherapy, surgery, hormones) that are used to treat breast cancer, impact breast cancer risk for women with the KRAS-variant.
Read More ➝- « Previous
- 1
- 2
- 3
Disclaimer
Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
